Durabolin Interactions
There are 85 drugs known to interact with Durabolin (nandrolone), along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 11 are major, and 74 are moderate.
- View all 85 medications that may interact with Durabolin
- View Durabolin alcohol/food interactions (1)
- View Durabolin disease interactions (10)
Most frequently checked interactions
View interaction reports for Durabolin (nandrolone) and the medicines listed below.
- Anadrol-50 (oxymetholone)
- anastrozole
- aspirin
- atorvastatin
- baclofen
- biotin
- boron
- Brilinta (ticagrelor)
- cabergoline
- chlorpromazine
- Cialis (tadalafil)
- ciprofloxacin ophthalmic
- clopidogrel
- Coenzyme Q10 (ubiquinone)
- creatine
- Creon (pancrelipase)
- D3 (cholecalciferol)
- Dexilant (dexlansoprazole)
- diazepam
- famotidine
- fexofenadine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flomax (tamsulosin)
- fluorouracil topical
- Folcaps Omega 3 (multivitamin, prenatal)
- gabapentin
- Gemtesa (vibegron)
- Hair Booster (multivitamin with minerals)
- HCG (chorionic gonadotropin (hcg))
- L-Tyrosine (tyrosine)
Durabolin alcohol/food interactions
There is 1 alcohol/food interaction with Durabolin (nandrolone).
Durabolin disease interactions
There are 10 disease interactions with Durabolin (nandrolone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- diabetes
- hypercalcemia
- thyroid function tests
Report options
QR code containing a link to this page
More about Durabolin (nandrolone)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: androgens and anabolic steroids
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
